Medtech June 2020

Our annual medtech edition is now live in an 'online-first' digital format.

Like Comment

Our online-first medtech edition features a series of companies developing and delivering new innovations and looking to find industry partners.  

We also explore the recent dealmaking, financing and licensing trends in the medtech field in our editorial feature. 

Read the full issue here.

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.